Moelis & Company (NYSE:MC - Free Report) - Equities research analysts at Zacks Research lifted their FY2025 EPS estimates for shares of Moelis & Company in a research note issued on Tuesday, August 19th. Zacks Research analyst Team now anticipates that the asset manager will earn $2.27 per share for the year, up from their previous forecast of $2.26. Zacks Research has a "Strong-Buy" rating on the stock. The consensus estimate for Moelis & Company's current full-year earnings is $2.97 per share. Zacks Research also issued estimates for Moelis & Company's Q4 2025 earnings at $0.63 EPS, Q1 2026 earnings at $0.69 EPS, Q2 2026 earnings at $0.63 EPS, Q3 2026 earnings at $0.69 EPS, FY2026 earnings at $2.77 EPS, Q1 2027 earnings at $0.93 EPS, Q2 2027 earnings at $0.98 EPS and FY2027 earnings at $4.06 EPS.
Other research analysts have also recently issued research reports about the stock. Morgan Stanley upgraded shares of Moelis & Company from an "underweight" rating to an "overweight" rating and boosted their price target for the stock from $42.00 to $68.00 in a report on Monday, June 23rd. JPMorgan Chase & Co. lowered their price target on shares of Moelis & Company from $55.00 to $52.00 and set a "neutral" rating for the company in a report on Thursday, April 24th. JMP Securities reiterated a "market perform" rating on shares of Moelis & Company in a report on Thursday, April 24th. Keefe, Bruyette & Woods boosted their price target on shares of Moelis & Company from $69.00 to $89.00 and gave the stock an "outperform" rating in a report on Monday, July 14th. Finally, Wells Fargo & Company boosted their price target on shares of Moelis & Company from $50.00 to $64.00 and gave the stock an "equal weight" rating in a report on Friday, July 11th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $66.00.
Get Our Latest Analysis on MC
Moelis & Company Stock Down 1.6%
NYSE MC opened at $70.2290 on Thursday. Moelis & Company has a 52 week low of $47.00 and a 52 week high of $82.89. The stock has a market capitalization of $5.51 billion, a PE ratio of 27.65 and a beta of 1.70. The firm has a 50 day moving average of $67.11 and a two-hundred day moving average of $62.91.
Moelis & Company (NYSE:MC - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The asset manager reported $0.53 EPS for the quarter, topping the consensus estimate of $0.32 by $0.21. Moelis & Company had a net margin of 14.31% and a return on equity of 42.72%. The company had revenue of $365.38 million during the quarter, compared to analysts' expectations of $269.57 million. During the same quarter in the previous year, the business posted $0.18 EPS. The firm's revenue was up 38.1% on a year-over-year basis.
Moelis & Company Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 18th. Stockholders of record on Monday, August 4th will be issued a $0.65 dividend. The ex-dividend date is Monday, August 4th. This represents a $2.60 annualized dividend and a dividend yield of 3.7%. Moelis & Company's dividend payout ratio is presently 102.36%.
Insider Activity
In other news, General Counsel Osamu R. Watanabe sold 6,340 shares of the company's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $72.64, for a total value of $460,537.60. Following the completion of the transaction, the general counsel owned 131 shares in the company, valued at approximately $9,515.84. This represents a 97.98% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 6.40% of the company's stock.
Institutional Trading of Moelis & Company
A number of large investors have recently bought and sold shares of MC. Barclays PLC boosted its stake in Moelis & Company by 1.3% during the 4th quarter. Barclays PLC now owns 143,951 shares of the asset manager's stock worth $10,635,000 after purchasing an additional 1,813 shares during the period. Canada Pension Plan Investment Board acquired a new stake in Moelis & Company during the 4th quarter worth $1,441,000. CANADA LIFE ASSURANCE Co boosted its stake in Moelis & Company by 2.8% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 81,534 shares of the asset manager's stock worth $6,024,000 after purchasing an additional 2,248 shares during the period. MetLife Investment Management LLC boosted its stake in Moelis & Company by 7.2% during the 4th quarter. MetLife Investment Management LLC now owns 42,623 shares of the asset manager's stock worth $3,149,000 after purchasing an additional 2,850 shares during the period. Finally, Tower Research Capital LLC TRC boosted its stake in Moelis & Company by 117.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 4,015 shares of the asset manager's stock worth $297,000 after purchasing an additional 2,170 shares during the period. Institutional investors and hedge funds own 91.53% of the company's stock.
Moelis & Company Company Profile
(
Get Free Report)
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.